Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
North Eastern German Society of Gynaecological Oncology
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
patients with primary ovarian cancer
ECOG- 0-2
Age \>= 18
no chemotherapy, radiation or immunotherapy in medical history for ovarian cancer
adequate bone marrow, liver and kidney reserve: leukocytes ≥ 2.0 x 109/l, platelets ≥ 100 x 109/l, bilirubin \<= 2,0 mg%, creatinine \<= 1,5 mg% or creatinine clearance ≥ 60 ml/ min, hemoglobin ≥ 9 g/ dl SGOT, SGPT an AP within 3 fold of the reference laboratory's normal range
written informed consent
You may not be if
before-existing heart illness, Cardiac infarct within last 6 months
Radiotherapy within 4 weeks for study entry
Patients in pregnancy or breast feeding (in premenopausal women anticonception has to be assured: intrauterine devices, surgical methods of sterilization, or, in hormone insensitive tumors only, oral, subcutaneous or transvaginal hormonal, non-estrogen containing contraceptives)
Clareo Health | Taxol Carboplatin and Erythropoetin
